Teva wins FDA nod for copycat ViiV drug; Medco loses pharma contract to CVS;

 @FiercePharma: Abbott down after NIH halts Niaspan study. News | Follow @FiercePharma

> Teva Pharmaceutical Industries has obtained FDA approval for its generic version of Combivir tablets, an HIV treatment made by ViiV Healthcare. News

> Chinese authorities have arrested hundreds of people accused of manufacturing and selling fake pharmaceuticals in the country's Zhejiang province. Story

> Sun Pharmaceutical said fourth-quarter profit rose 12 percent, beating analyst estimates as sales at its Taro Pharmaceutical unit jumped. News

> Medco Health Solutions will lose a major pharmacy benefit contract to CVS Caremark starting next year, a setback that sparked further concerns about its ability to retain business. Report

> Somaxon Pharmaceuticals has filed a patent-infringement lawsuit against Par Pharmaceutical, following the latter's request for approval to market generic versions of sleep aid Silenor in the U.S. Piece

> U.K. contract manufacturing organisation SCM Pharma has won a contract to supply a cancer drug due to start rolling out in Europe later this year. Report

> International health alliance GAVI is seeking $3.7 billion from pledging conference to help deliver vaccines to nearly a quarter of a billion children across the world by 2015. Item

> Belgian health products distributor Omega Pharma said it was premature to report it was planning to delist from the stock market. Story

Biotech News 

@FierceBiotech: Rigel raises $130M for PhII trial of asthma drug. Article |  Follow @FierceBiotech

@JohnCFierce:  Lights out for Renovo as staff is let go and assets auctioned off. UK biotech done in by unsuccessful Ph3 for Juvista. News | Follow @JohnCFierce

> Sanofi touts promising Ph3 results for blockbuster diabetes program. Story

> Booming AVEO inks $555M antibody deal with J&J. News 

> GSK burnishes its "open innovation" rep with new translational research fund. Article

> Amarin sets stage for "aggressive" launch of omega 3 drug. Item 

> Biotech upstart raises $10.5M for MRSA antibody. News 

Biotech IT News

> U. Maryland hooks up with OpGen on microbial database. Article 

> 23andMe eyes Big Pharma for future growth. Report

> Just one word... bioinformatics. Story

> Oracle, others plan NY clinical research network. News

Biotech Research News

> Researchers help lab mice better reflect human genetic diversity. Article

> Carbon nanotube patch could regenerate heart tissue after attack. Report 

> A gene gone wild may cause stomach cancer. News 

> Researchers establish link between obesity, vitamin D levels. Report 

> ViaCyte progresses toward trials in stem cell diabetes treatment. News 

> Skin cells transformed directly into neurons. Story

Manufacturing News

> 11 plead guilty in fake Avastin case. Report

> India sees rise in post-vax deaths. Item

> Serialization slowly losing sleeper status. Article 

> FDA posts inspection findings, common violations. Story 

> BMS streamlines data matrix coding. Item

And Finally... Researchers found that adopting new, more sophisticated electronic prescribing systems led to an overall drop in errors, but certain types of errors actually increased just after the switch. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.